1-7 of 7
Masahito Ishikawa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic Impact of Recurrence Pattern for Surgically Resected Non-Small Cell Lung Cancer

Available to Purchase
Subject Area:
Oncology
Nozomu Motono, Takaki Mizoguchi, Masahito Ishikawa, Shun Iwai, Yoshihito Iijima, Hidetaka Uramoto
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000545310
Published Online: 24 April 2025
View articletitled, Prognostic Impact of Recurrence Pattern for Surgically Resected Non-Small Cell Lung Cancer
Open the PDF for Prognostic Impact of Recurrence Pattern for Surgically Resected Non-Small Cell Lung Cancer in another window
Journal Articles

The Utility of the New Category by Number of Stations for Lymph Nodal Involvement in Non-Small Cell Lung Cancer

Available to Purchase
Subject Area:
Oncology
Nozomu Motono, Takaki Mizoguchi, Masahito Ishikawa, Shun Iwai, Yoshihito Iijima, Hidetaka Uramoto
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000545002
Published Online: 21 March 2025
View articletitled, The Utility of the New Category by Number of Stations for Lymph Nodal Involvement in Non-Small Cell Lung Cancer
Open the PDF for The Utility of the New Category by Number of Stations for Lymph Nodal Involvement in Non-Small Cell Lung Cancer in another window
Journal Articles

Prognostic Factors among Patients with Resected Non-Adenocarcinoma of the Lung

Available to Purchase
Subject Area:
Oncology
Nozomu Motono, Takaki Mizoguchi, Masahito Ishikawa, Shun Iwai, Yoshihito Iijima, Hidetaka Uramoto
Journal: Oncology
Oncology (2024) 102 (9): 739–746.
https://doi.org/10.1159/000536276
Published Online: 24 January 2024
View articletitled, Prognostic Factors among Patients with Resected Non-Adenocarcinoma of the Lung
Open the PDF for Prognostic Factors among Patients with Resected Non-Adenocarcinoma of the Lung in another window
Journal Articles

Relative Efficacies of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors for Treatment of Recurrent Non-Small Cell Lung Cancer after Surgery

Free
Subject Area:
Oncology
Nozomu Motono, Takaki Mizoguchi, Masahito Ishikawa, Shun Iwai, Yoshihito Iijima, Hidetaka Uramoto
Journal: Oncology
Oncology (2024) 102 (6): 476–483.
https://doi.org/10.1159/000534814
Published Online: 20 November 2023
View articletitled, Relative Efficacies of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors for Treatment of Recurrent Non-Small Cell Lung Cancer after Surgery
Open the PDF for Relative Efficacies of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors for Treatment of Recurrent Non-Small Cell Lung Cancer after Surgery in another window
Journal Articles

Association between Lower Lobe Location and Early Recurrence for Non-Small Cell Lung Cancer

Available to Purchase
Subject Area:
Oncology
Nozomu Motono, Takaki Mizoguchi, Masahito Ishikawa, Shun Iwai, Yoshihito Iijima, Hidetaka Uramoto
Journal: Oncology
Oncology (2024) 102 (6): 441–446.
https://doi.org/10.1159/000533603
Published Online: 07 November 2023
View articletitled, Association between Lower Lobe Location and Early Recurrence for Non-Small Cell Lung Cancer
Open the PDF for Association between Lower Lobe Location and Early Recurrence for Non-Small Cell Lung Cancer in another window
Journal Articles

Predictive Value of Recurrence of Solid and Micropapillary Subtypes in Lung Adenocarcinoma

Available to Purchase
Subject Area:
Oncology
Nozomu Motono, Takaki Mizoguchi, Masahito Ishikawa, Shun Iwai, Yoshihito Iijima, Hidetaka Uramoto
Journal: Oncology
Oncology (2024) 102 (4): 366–373.
https://doi.org/10.1159/000530528
Published Online: 27 October 2023
View articletitled, Predictive Value of Recurrence of Solid and Micropapillary Subtypes in Lung Adenocarcinoma
Open the PDF for Predictive Value of Recurrence of Solid and Micropapillary Subtypes in Lung Adenocarcinoma in another window
Journal Articles

The Utility of SUV max as an Adaptation Criterion for Limited Resection in Stage IA Non-Small Cell Lung Cancer

Free
Subject Area:
Topic Article Package: ADC (Antibody-Drug Conjugates) , Karger e-Journal Backfile Collection 2023 , Oncology
Nozomu Motono, Takaki Mizoguchi, Masahito Ishikawa, Shun Iwai, Yoshihito Iijima, Hidetaka Uramoto
Journal: Oncology
Oncology (2023) 101 (8): 473–480.
https://doi.org/10.1159/000530314
Published Online: 11 July 2023
View articletitled, The Utility of SUV max as an Adaptation Criterion for Limited Resection in Stage IA Non-Small Cell Lung Cancer
Open the PDF for The Utility of SUV max as an Adaptation Criterion for Limited Resection in Stage IA Non-Small Cell Lung Cancer in another window